Loading stock data…
ASTH
$34.89+0.75 (+2.20%)
Market ClosedLast close May 1
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Astrana Health, Inc. in the Healthcare sector is trading at $34.89. The stock is currently near its 52-week high of $35.38, remaining 32.2% above its 200-day moving average. Technical signals show overbought RSI of 82 and bullish MACD crossover, explaining why ASTH maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 82) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$34.89
Potential Downside
74.5%
Whystock Fair Value$8.88
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.88B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
73.26
Beta
Defensive asset. Lower volatility than the S&P 500.
0.77
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.24%
Volume
Today's trading volume
435,861
Recent News
1 Healthcare Stock to Target This Week and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 1.9% gain for healthcare stocks has fallen short of the S&P 500’s 6.1% rise.
Is the Options Market Predicting a Spike in Astrana Health Stock?
Investors need to pay close attention to ASTH stock based on the movements in the options market lately.
1 Surging Stock with Competitive Advantages and 2 We Ignore
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, investors are taking notice and bidding up shares.
3 Growth Stocks to Add to Your Roster
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
2 Stocks Under $50 for Long-Term Investors and 1 Facing Challenges
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.